Book of Medical Disorders in Pregnancy - Tintash
Book of Medical Disorders in Pregnancy - Tintash
Book of Medical Disorders in Pregnancy - Tintash
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
effects or malformations have been reported.<br />
Theophyll<strong>in</strong>e pharmacok<strong>in</strong>etics<br />
are unaffected by pregnancy, and this<br />
drug also appears <strong>in</strong> breast milk.<br />
Betagonists:<br />
These have little systemic absorption<br />
and a more potent bronchodilatory effect<br />
via <strong>in</strong>halation. Data on the use <strong>of</strong> <strong>in</strong>haled<br />
beta-agonists showed no difference <strong>in</strong><br />
per<strong>in</strong>atal mortality, congenital malformations,<br />
birth weight, or Apgar scores.<br />
Corticosteroids:<br />
The use <strong>of</strong> corticosteroids dur<strong>in</strong>g<br />
pregnancy cont<strong>in</strong>ues to be controversial,<br />
although numerous reports confirm their<br />
use without adverse fetal effects. In 3<br />
reports on human pregnancies, no congenital<br />
malformations or adverse fetal<br />
effects were found from <strong>in</strong>haled corticosteroids.<br />
Prednisone has been used extensively<br />
dur<strong>in</strong>g pregnancy for a variety <strong>of</strong><br />
conditions. It is associated with an<br />
<strong>in</strong>creased <strong>in</strong>cidence <strong>of</strong> cleft palates <strong>in</strong><br />
animals but not <strong>in</strong> humans.<br />
Ipratropium and bromide:<br />
Neither <strong>of</strong> these medications has been<br />
associated with adverse fetal outcomes.<br />
Antihistam<strong>in</strong>es and decongestants:<br />
Patients frequently request these<br />
medications for nasal symptoms,<br />
mucosal edema, and hyperemia that<br />
accompany normal pregnancy. The<br />
available data does not <strong>in</strong>dicate safety <strong>of</strong><br />
antihist-am<strong>in</strong>es <strong>in</strong> pregnancy.<br />
Brompheniram<strong>in</strong>e is associated with<br />
congenital malformations.<br />
102<br />
Common antibiotics used for<br />
respiratory <strong>in</strong>fections:<br />
The major antibiotics considered safe<br />
dur<strong>in</strong>g pregnancy are penicill<strong>in</strong>, cephalospor<strong>in</strong>s,<br />
and erythromyc<strong>in</strong>. Although<br />
penicill<strong>in</strong> and ampicill<strong>in</strong> readily cross<br />
the placenta, no adverse effects to the<br />
fetus are reported. Cephalospor<strong>in</strong>s also<br />
traverse the placenta to a moderate<br />
degree, but no adverse fetal effects<br />
occur. Erythromyc<strong>in</strong> crosses the placenta<br />
to a low degree but achieves high levels<br />
<strong>in</strong> breast milk. The estolate formulation<br />
is contra<strong>in</strong>dicated due to potential<br />
hepatic toxicity <strong>in</strong> the mother. Antibiotics<br />
that have relative contra<strong>in</strong>-dications<br />
<strong>in</strong>clude sulfonamides, trime-thoprim,<br />
am<strong>in</strong>oglycosides, nitr<strong>of</strong>uran-to<strong>in</strong>,<br />
antituberculosis drugs, tetracyc-l<strong>in</strong>es,<br />
and qu<strong>in</strong>olones.<br />
Teratogens used <strong>in</strong> pulmonary<br />
disease:<br />
These drugs <strong>in</strong>clude iod<strong>in</strong>e-conta<strong>in</strong><strong>in</strong>g<br />
compounds. Brompheniram<strong>in</strong>e, antihistam<strong>in</strong>e,<br />
coumar<strong>in</strong>, and anticoagulants cause<br />
various teratogenic effects. Cipr<strong>of</strong>loxac<strong>in</strong>,<br />
sulfonamides, tetracycl<strong>in</strong>es, chloramphenicol,<br />
streptomyc<strong>in</strong>, and rifamp<strong>in</strong><br />
have been associated with various<br />
effects. Ioniz<strong>in</strong>g radiation exposure to<br />
the fetus is associated with growth<br />
retardation, CNS effects, microcephaly,<br />
and eye malformations.<br />
Maternal radiation exposure <strong>of</strong> less than<br />
0.05 Gy is associated with no adverse<br />
effects, a dose <strong>of</strong> 0.05-0.1 Gy is<br />
considered the gray zone, and exposure<br />
to more than 0.1 Gy is associated with<br />
significant fetal effects. Fetal ioniz<strong>in</strong>g<br />
radiation might cause <strong>in</strong>creases <strong>in</strong><br />
childhood leukemia. A chest radiograph<br />
results <strong>in</strong> 0.002-Gy exposure; perfusion<br />
lung scan, 0.002 Gy; ventilation lung